CAS 38668-01-8: 1,2,4-thiadiazinane 1,1-dioxide

Taurultam is a taurolidine analog that has anti-angiogenic effects. The drug has been shown to inhibit tumor cell viability and induce apoptosis in cancer cells. Taurultam also inhibits the growth of bacteria by binding to the cytochrome b of mitochondrial respiratory chain, preventing electron transport and oxidative phosphorylation. Taurultam is used as a broad-spectrum antimicrobial agent, which is effective against Gram-positive and Gram-negative bacteria, including those with resistance to other antibiotics. It also has anti-inflammatory properties and inhibits inflammatory bowel disease in rats. Taurultam may be useful for treating bone cancer or fetal bovine serum because it does not affect normal cells.

Applications Taurultam is a compound that inhibits cell proliferation and cell adhesion in angiogenesis. Taurultam exhibits bacteriocidal effects on Escherichia coli and is also a degradation product of Taurolidine (T009050). References Jones, D., et al.: Lett. Appl. Micro., 14, 5 (1992); Kirsch, L. & Sinn, Y.: Pharm. Dev. Tech., 2, 345 (1997); Mšhler, T., et al.: Cancer Therapy, 6, 623 (2008)